<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1496078</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2024.1496078</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Anti-inflammatory and antioxidant properties of oleuropein in human keratinocytes characterized by bottom-up proteomics</article-title>
<alt-title alt-title-type="left-running-head">Li et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2024.1496078">10.3389/fphar.2024.1496078</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Huifang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1742640/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Ni</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Jiayi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2885954/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Xiaoxuan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Ang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2038407/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seeram</surname>
<given-names>Navindra P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/project administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Hang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1519539/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/project administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Dongli</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/project administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Huilan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/project administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Chang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1734878/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Bioactive Botanical Research Laboratory</institution>, <institution>Department of Biomedical and Pharmaceutical Sciences</institution>, <institution>College of Pharmacy</institution>, <institution>University of Rhode Island</institution>, <addr-line>Kingston</addr-line>, <addr-line>RI</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Proteomics Facility</institution>, <institution>College of Pharmacy</institution>, <institution>University of Rhode Island</institution>, <addr-line>Kingston</addr-line>, <addr-line>RI</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Outpatient Department</institution>, <institution>Southern Theater Command General Hospital</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Pharmacy and Food Engineering</institution>, <institution>Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine</institution>, <institution>Wuyi University</institution>, <addr-line>Jiangmen</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1316669/overview">Zhanyong Wang</ext-link>, Shenyang Agricultural University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1827117/overview">Navkiran Kaur</ext-link>, Amity University, India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2908364/overview">Javed Ahamad</ext-link>, Tishk International University (TIU), Iraq</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Dongli Li, <email>wyuchemldl@wyu.edu.cn</email>; Huilan Yang, <email>huilany88@vip.163.com</email>; Chang Liu, <email>hichang813@uri.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1496078</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>09</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Li, Deng, Yang, Zhao, Jin, Cai, Seeram, Ma, Li, Yang and Liu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Li, Deng, Yang, Zhao, Jin, Cai, Seeram, Ma, Li, Yang and Liu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Oleuropein is a phenolic compound commonly found in cosmetic ingredients including olive leaves and jasmine flowers with various skin-beneficial effects. Here, we evaluated oleuropein&#x2019;s anti-inflammatory and antioxidant activities in human skin cells. In a cell-based inflammasome model with human monocytes (THP-1 cells), oleuropein (12&#x2013;200&#xa0;&#xb5;M) reduced proinflammatory cytokine interleukin (IL)-6 by 38.8%&#x2013;45.5%, respectively. Oleuropein (50 and 100&#xa0;&#xb5;M) also alleviated oxidative stress in keratinocytes (HaCaT cells) by reducing H<sub>2</sub>O<sub>2</sub>-induced cell death by 6.4% and 9.2%, respectively. Additionally, biological evaluations revealed that oleuropein&#x2019;s antioxidant effects were attributed to its mitigation of reactive oxygen species in HaCaT cells. Furthermore, a multiplexed gene assay identified IL-1&#x3b2; and thioredoxin-interacting proteins as potential molecular targets involved in oleuropein&#x2019;s protective effects in HaCaT cells. This was supported by findings from several cellular assays showing that oleuropein reduced the level of IL-1&#x3b2; and inhibited the activity of caspase-1/IL-1 converting enzyme, as well as ameliorated pyroptosis in HaCaT cells. Moreover, a bottom-up proteomics study was conducted to explore potential molecular targets and signaling pathways involved in oleuropein&#x2019;s antioxidant activities. Taken together, findings from this study expand the understanding of oleuropein&#x2019;s skin protective effects against oxidative and inflammatory stresses, which support that oleuropein is a promising natural cosmeceutical for skincare applications.</p>
</abstract>
<kwd-group>
<kwd>oleuropein</kwd>
<kwd>skin</kwd>
<kwd>antioxidant</kwd>
<kwd>inflammasome</kwd>
<kwd>caspase</kwd>
<kwd>proteomics</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Keratinocytes are the primary cells of the epidermis, the outermost layer of human skin, responsible for maintaining the immune barrier and promoting healing in response to both external (e.g., open wounds) and internal (e.g., free radicals and toxins) stressors (<xref ref-type="bibr" rid="B25">Piipponen et al., 2020</xref>). Compromised keratinocytes can lead to impaired skin barrier function and exacerbate signs of aging, such as fine lines and wrinkles. Consequently, there has been significant research interest in identifying compounds that protect keratinocytes from oxidative and inflammatory stress. Natural products derived from medicinal plants and functional foods have emerged as promising bioactives for skin protection. Among these, oleuropein (OLE), a phenolic compound found in olives and jasmine, has demonstrated various skin benefits. For example, OLE has been shown to enhance wound healing by increasing vascular endothelial growth factor (VEGF) and promoting angiogenesis, thus facilitating the formation of new blood vessels at wound sites (<xref ref-type="bibr" rid="B1">Allaw et al., 2021</xref>). Additionally, OLE reduces cell infiltration to wound sites, increases collagen fiber deposition, and accelerates the replacement of lost or damaged epithelial cells (<xref ref-type="bibr" rid="B24">Omar, 2010</xref>). The wound-healing properties of OLE are primarily attributed to its antioxidant activity, which reduces free radicals in skin tissues, aiding in wound recovery. OLE also exhibits anti-inflammatory effects, as demonstrated in a diabetic mouse model (<xref ref-type="bibr" rid="B19">Liu et al., 2022</xref>). Although our laboratory previously reported that OLE confers cytoprotective effects in human dermal fibroblast cells by mitigating H<sub>2</sub>O<sub>2</sub>-induced oxidative stress (<xref ref-type="bibr" rid="B12">Li et al., 2022</xref>), the specific molecular targets (i.e., genes and proteins) involved in OLE&#x2019;s cytoprotective effects on skin remain unclear. Therefore, the current study aims to characterize the antioxidant and anti-inflammatory effects of OLE in human keratinocytes (HaCaT cells) and to identify potential biomarkers, including genes and proteins, that contribute to its cytoprotective activities. We employed a combination of biochemical methods, such as a multigene plex assay, and a bottom-up proteomic approach to identify genes and proteins that may play critical roles in OLE&#x2019;s biological activities, providing a comprehensive analysis of its mechanisms of action.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Chemicals</title>
<p>Oleuropein (OLE) was purchased from Cayman Chemical (Ann Arbor, MI, United States). 2&#x2032;,7&#x2032;-dichlorofluorescin diacetate (DCFDA), dimethyl sulfoxide (DMSO), phorbol 12-myristate 13-acetate (PMA), and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) solution were purchased from Sigma Aldrich (St. Louis, MO, United States). Cell Titer-Glo<sup>&#xae;</sup> (CTG) 2.0 assay kit was purchased from Promega (Fitchburg, WI, United States). CyQUANT&#x2122; XTT Cell Viability Assay kit from Thermo Fisher Scientific (Waltham, MA, United States).</p>
</sec>
<sec id="s2-2">
<title>2.2 Cell culture and viability</title>
<p>Human monocyte THP-1 cells and Human keratinocyte HaCaT cells were purchased from the American Type Culture Collection (Rockville, MD, United States) and grown in Roswell Park Memorial Institute (RPMI) 1,640 medium and Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM) (Life Technologies, Gaithersburg, MD, United States) with 10% fetal bovine serum (FBS) (Life Technologies) at 37&#xb0;C and 5% CO<sub>2</sub> at constant humidity. OLE was dissolved in DMSO (dimethyl sulfoxide) and then diluted with a cell culture medium to the desired concentrations. The cytotoxicity of OLE in THP-1 monocytes was measured using an XTT assay. Briefly, THP-1 monocytes were seeded into a 96-well plate at 1&#xd7;10<sup>4</sup> cells per well and incubated with PMA (25&#xa0;nM) for 48&#xa0;h, then changed to PMA-free medium for another 24&#xa0;h. Then cells were treated with OLE (at concentrations of 25, 50, 100, and 200&#xa0;&#xb5;M) in the presence or absence of LPS (100&#xa0;ng/mL) for 24&#xa0;h. The XTT regent (50&#xa0;&#x3bc;L) was added into each well and incubated for 4&#xa0;h then the absorbance of each well was recorded at the wavelengths of 492 and 650&#xa0;nm using a SpectraMax M2 plate reader (Molecular Devices, Sunnyvale, CA). The cytotoxicity of OLE in a model of H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity in HaCaT cells was measured using a CTG 2.0 assay. HaCaT cells were seeded in 96-well plates at 6&#xd7;10<sup>3</sup> cells per well and allowed to attach, then incubated with OLE for 2&#xa0;h and incubated for 22&#xa0;h without or with H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#xb5;M) (<xref ref-type="bibr" rid="B15">Liu et al., 2019</xref>). Next, CTG 2.0 reagent (100&#xa0;&#xb5;L) was added to each well and shaken at 200&#xa0;rpm for 2&#xa0;min on an orbital shaker. The plate was then incubated at 37&#xb0;C for 20&#xa0;min, followed by measuring the luminescence intensity of each well using a plate reader.</p>
</sec>
<sec id="s2-3">
<title>2.3 Measurement of cytokines</title>
<p>The anti-inflammasome activity of OLE was evaluated by measuring the LPS- and nigericin-induced cytokines according to a reported method (<xref ref-type="bibr" rid="B17">Liu et al., 2020</xref>). Briefly, THP-1 cells were seeded at a density of 5 &#xd7; 10<sup>4</sup> cells per well in a 48-well plate with PMA (25&#xa0;ng/mL) for 48&#xa0;h, then incubated with PMA-free complete medium for 24&#xa0;h. Next, OLE (at concentrations of 25, 50, 100, and 200&#xa0;&#x3bc;M) was incubated with cells for 1&#xa0;h followed by adding LPS (100&#xa0;ng/mL; incubation for 4&#xa0;h) then added nigericin (10&#xa0;&#x3bc;M) for 1&#xa0;h. Cell culture supernatant was collected to measure IL-1&#x3b2; and IL-6 by the ELISA kits (BioLegend, San Diego, CA, United States).</p>
</sec>
<sec id="s2-4">
<title>2.4 Non-contact co-culture model with HaCaT and THP-1 cells</title>
<p>HaCaT and THP-1 cells were co-cultured as previously reported (<xref ref-type="bibr" rid="B21">Ma et al., 2016</xref>). Briefly, THP-1 monocytes were seeded into a 48-well plate at 2.5 &#xd7; 10<sup>4</sup> cells per well and incubated with PMA (25&#xa0;nM) for 48&#xa0;h, then changed to PMA-free medium for another 24&#xa0;h. Then cells were treated with OLE (at concentrations of 25, 50, 100, and 200&#xa0;&#xb5;M) for 1&#xa0;h in the presence or absence of LPS (100&#xa0;ng/mL) for 1&#xa0;h, then added nigericin (10&#xa0;&#xb5;M) for 1&#xa0;h and got the supernatant. HaCaT cells were plated in 96-well plates at a density of 6 &#xd7; 10<sup>3</sup> cells/mL and incubated it overnight, then removed and replaced with the supernatant from the THP-1 cells for 24-h incubation. The cell viability of HaCaT cells was evaluated by an XTT assay.</p>
</sec>
<sec id="s2-5">
<title>2.5 Measurement of reactive oxygen species (ROS)</title>
<p>HaCaT cells were seeded in 96-well plates at 6 &#xd7; 10<sup>3</sup> cells per well and allowed to attach, then incubated with test samples (at 12.5&#x2013;100&#xa0;&#xb5;M) for 24&#xa0;h. Next, the cell culture medium was removed and 100&#xa0;&#xb5;L medium containing a fluorescent probe 2&#x2032;,7&#x2032;-dichlorofluorescin diacetate (DCFDA; 20&#xa0;&#x3bc;M) was added to the cells and incubated for 20&#xa0;min. Then cells were treated with 100&#xa0;&#xb5;L H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#xb5;M) for 1&#xa0;h, followed by measuring the fluorescence intensity of each well with excitation and emission wavelengths of 485 and 525&#xa0;nm, respectively, by a plate reader. Flow cytometry-based assays with specific staining reagents were used to detect ROS levels from mitochondria as we previously reported (<xref ref-type="bibr" rid="B16">Liu et al., 2021</xref>). Briefly, HaCaT cells were seeded in 6-well plates at 5 &#xd7; 10<sup>5</sup> cells per well and allowed to attach, then the medium was removed, and cells were incubated with OLE (100&#xa0;&#x3bc;M) for 6&#xa0;h. Next, cells were stimulated with H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#x3bc;M) for 1&#xa0;h and then stained with MitoSOX reagent for 30&#xa0;min. The fluorescent intensity of cell suspensions was quantified using flow cytometry (BD FACS Calibur; San Jose, CA, United States) and data were analyzed using the software FlowJo (Ashland, OR, United States).</p>
</sec>
<sec id="s2-6">
<title>2.6 Quanti-geneplex assay</title>
<p>The multiplexed gene expression assay was performed according to the kit instruction of QuantiGeneTM plex gene expression assay kit (Thermo Fisher Scientific; Waltham, MA, United States). The expression of transcripts related to inflammation pathways was measured using a customized QuantiGene panel in HaCaT cells. The cells were seeded in 48-well plates at 5 &#xd7; 10<sup>4</sup> cells per well and allowed to attach. Then the medium was removed, and cells were incubated with OLE (100&#xa0;&#x3bc;M) for 6&#xa0;h. Next, a working lysis mixture was added and incubated at 55&#xb0;C for 30&#xa0;min, and then cell lysis was hybridized with specific target probe sets for 12&#xa0;h. The signal of each gene was then generated and amplified by the SP (<italic>Streptavidin phycoerythrin</italic>) fluorescence amplification assay. The mean fluorescence intensity was quantified using a Bio-plex 200 instrument (BioRad; Hercules, CA, United States).</p>
</sec>
<sec id="s2-7">
<title>2.7 Measurement of cellular IL-1&#x3b2;</title>
<p>HaCaT cells were seeded in 6-well plates at 5 &#xd7; 10<sup>5</sup> cells per well and allowed to attach for 12&#xa0;h. Cells were then incubated with OLE (12.5&#x2013;100&#xa0;&#x3bc;M) for 6&#xa0;h and stimulated with H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#x3bc;M) for 24&#xa0;h, and the cells were collected to extract cell proteins. The level of cellular IL-1&#x3b2; was determined using an ELISA kit (Biolegend; San Diego, CA, United States) according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2-8">
<title>2.8 Caspase-1 enzyme activity assay</title>
<p>A caspase-1/ICE colorimetric assay kit (R&#x26;D Systems; Minneapolis, MN, United States) was used to evaluate the activity of the caspase-1 enzyme. HaCaT cells were cultured in 6-well plates at 5 &#xd7; 10<sup>5</sup> cells per well for 24&#xa0;h and then collected in a conical tube. The cell pellet was lysed with cold lysis buffer (25&#xa0;&#x3bc;L/1 &#xd7; 10<sup>6</sup> cells) and incubated at 4&#xb0;C for 10&#xa0;min. The enzymatic reaction for caspase activity was performed in a 96-well microplate containing cell lysate (50&#xa0;&#x3bc;L), reaction buffer (containing 1% dithiothreitol; 50&#xa0;&#x3bc;L), and caspase-1 enzyme substrate (YVAD-Pna; 5&#xa0;&#x3bc;L). The reaction was incubated in the presence or absence of OLE (100&#xa0;&#x3bc;M) at 37&#xb0;C for 2&#xa0;h and the optical density of each well was recorded using a plate reader at a wavelength of 405&#xa0;nm.</p>
</sec>
<sec id="s2-9">
<title>2.9 Lactate dehydrogenase assay</title>
<p>Pyroptosis was measured by a lactate dehydrogenase (LDH) assay purchased from Sigma Aldrich. Briefly, HaCaT cells were seeded in 96-well plates at 6 &#xd7; 10<sup>3</sup> cells per well and incubated for 12&#xa0;h. Next, the cells were treated with OLE (12.5&#x2013;100&#xa0;&#x3bc;M) for 6&#xa0;h and followed by incubation with H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#x3bc;M) for 24&#xa0;h. The LDH master reaction mix (50&#xa0;&#x3bc;L) containing the LDH assay buffer, LDH substrate, and collected cell supernatant was kept on a horizontal shaker in the dark for 2&#xa0;min. Then the plate was incubated at 37&#xb0;C for 5&#xa0;min and the absorbance of each well was recorded at a wavelength of 450&#xa0;nm using a plate reader.</p>
</sec>
<sec id="s2-10">
<title>2.10 Sample preparation for bottom-up proteomics analysis</title>
<p>Cell homogenization was performed after cell harvest and protein concentration was determined using a quantification assay. Protein extraction was conducted using a chloroform/methanol extraction method, followed by in-solution trypsin digestion, according to a standardized protocol previously established by our proteomics facility (<xref ref-type="bibr" rid="B27">Puopolo et al., 2024</xref>).</p>
</sec>
<sec id="s2-11">
<title>2.11 Liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis</title>
<p>Sequential window acquisition of all theoretical mass spectra (SWATH-MS) was performed on an AB Sciex TripleTOF 5,600 mass spectrometer with a DuoSpray&#x2122; ion source, coupled to an Acquity H Class HPLC system. An Acquity UPLC Peptide BEH C18 column (2.1 &#xd7; 150&#xa0;mm, 300&#xa0;&#xc5;, 1.7&#xa0;&#x3bc;m) with a VanGuard pre-column (2.1 &#xd7; 5&#xa0;mm, 300&#xa0;&#xc5;, 1.7&#xa0;&#x3bc;m) was used for sample separation at 50&#xb0;C. The autosampler was maintained at 10&#xb0;C. Separation was achieved using a 180-min gradient at a flow rate of 10&#xa0;&#x3bc;L/min, with mobile phases consisting of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). The gradient was as follows: 98% A (0&#x2013;5&#xa0;min), 98%&#x2013;70% A (5&#x2013;155&#xa0;min), 70%&#x2013;50% A (155&#x2013;160&#xa0;min), 50%&#x2013;5% A (160&#x2013;170&#xa0;min), and 5%&#x2013;98% A (170&#x2013;175&#xa0;min), followed by column re-equilibration. &#x3b2;-galactosidase was injected every four samples for TOF 5600 mass calibration. This method has been extensively used as reported in our previous publications (<xref ref-type="bibr" rid="B26">Puopolo et al., 2023</xref>).</p>
</sec>
<sec id="s2-12">
<title>2.12 Direct data-independent acquisition (DIA) analysis</title>
<p>DirectDIA analysis was conducted using spectral libraries generated from the <italic>Homo sapiens</italic> (Human) FASTA file from UniProt (A9X5H6). Digestion was performed with Trypsin/P, allowing up to two missed cleavages, and peptide lengths were set between 7 and 52 amino acids. Tolerance parameters were set to 1 for both MS1 and MS2 for calibration and the main search. The precursor Q-value cutoff was 0.01, and the precursor PEP cutoff was 0.2. Variable modifications included N-terminal acetylation and methionine oxidation. The False Discovery Rate (FDR) was controlled at 0.01&#xa0;at the peptide, protein, and peptide-spectrum match (PSM) levels. MS2 signal intensities of fragment ions were obtained from DIA data using Spectronaut&#x2122; Pulsar (version 18.0, Biognosys AG) with default settings. The report, exported in a. tsc format, was then used as input for the msDiaLogue package (<ext-link ext-link-type="uri" xlink:href="https://github.com/uconn-scs/msDiaLogue">https://github.com/uconn-scs/msDiaLogue</ext-link>). In the msDiaLogue package, a stringent filtering step was applied to exclude proteins identified by fewer than two peptides (stripped sequences), ensuring the reliability of protein identifications. Peptide (Stripped Sequence): This term refers to the amino acid sequence of a peptide, independent of its charge state or post-translational modifications. It is primarily used for protein inference in mass spectrometry-based proteomics. Additionally, an unpaired t-test was employed to compare two groups, and volcano plots were generated using a fold-change cut-off of 1.5 (log2 &#x3d; 0.58) and a <italic>p</italic>-value threshold of &#x3c;0.05.</p>
</sec>
<sec id="s2-13">
<title>2.13 Bioinformatic analysis</title>
<p>Ingenuity Pathway Analysis (IPA, Qiagen, version 01-2022-01) was performed to assess downstream event changes. Fold changes for the comparisons of Model vs Control and OLE treatment vs Model, along with corresponding <italic>p</italic>-values, were input into IPA to build the database. Fisher&#x2019;s Exact Test was used to identify associations between the input data and the established annotations within the IPA database, generating insights into canonical pathways, disease functions, and upstream regulators relevant to the dataset. The directionality of expression changes in the dataset was compared with expected patterns from literature annotations, and z-scores were calculated to determine the statistical significance of these predictions.</p>
</sec>
<sec id="s2-14">
<title>2.14 Statistical analysis</title>
<p>Data were shown as mean &#xb1; standard deviation (S.D) from three replicates of experiments. Statistical analysis was performed using GraphPad Prism 10 (GraphPad Software; La Jolla, CA, United States) using one-way analysis of variance with multiple comparisons. A <italic>p</italic>-value of less than 0.05 was considered as a statistical significance between the two groups.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 OLE inhibits LPS-nigericin-induced IL-6 secretion in THP-1 monocytes</title>
<p>We first evaluated OLE&#x2019;s effects on the viability of THP-1 monocytes with and without the presence of LPS. Treatment with OLE (25, 50, 100, and 200&#xa0;&#x3bc;M) was not toxic to THP-1 monocytes as the cell viability was higher than the control group&#x2019;s (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Similarly, in the presence of LPS (100&#xa0;ng/mL), there were no signs of cytotoxicity with the treatment of OLE (25&#x2013;200&#xa0;&#x3bc;M, cell viability &#x3e;100%) (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Next, the anti-inflammasome activity of OLE in THP-1 monocytes was evaluated in an inflammasome model induced by LPS-nigericin. Stimulation with LPS-nigericin significantly increased the concentration of IL-1&#x3b2; and IL-6 in THP-1 monocytes from 1.5 to 1,146.6&#xa0;pg/mL and from 0.7 to 203.5&#xa0;pg/mL, respectively, compared to the control group. Treatment with OLE (25, 50, 100, and 200&#xa0;&#x3bc;M) decreased the IL-6 secretion to 158.4, 167.3, 176.8, and 177.8&#xa0;pg/mL, respectively (<xref ref-type="fig" rid="F1">Figure 1C</xref>), while not significantly lowering the expression level of IL-1&#x3b2; (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Effects of OLE on the viability of THP-1 cells <bold>(A)</bold> without or <bold>(B)</bold> with the presence of LPS. &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 compared with or without the LPS-treated group. Effects of OLE on the LPS and nigericin-induced secretion of cytokines IL-6 <bold>(C)</bold>, and IL-1&#x3b2; <bold>(D)</bold> in THP-1 monocytes. <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.0001 as compared with control group, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 as compared with LPS &#x2b; Nig group.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 OLE protects HaCaT cells from inflammatory and oxidative stress</title>
<p>Co-culture models have been employed to investigate the impact of THP-1 cells and their inflammatory mediators on the cell death of HaCaT cells. Thus, we used a non-contact cell culture model with conditioned media to evaluate the protective effects of OLE against LPS-nigericin-induced inflammation and cytotoxicity. OLE reduced the cytotoxicity of HaCaT cells exposed to a conditioned medium from THP-1 cells. HaCaT cells exposed to THP-1 cell media showed reduced viability by 18.9% compared to the control group, while OLE at concentrations of 25, 50, 100, and 200&#xa0;&#xb5;M restored the HaCaT cell viability by 12.1%, 20.5%, 39.3%, and 59.0% compared to the model group, respectively (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Next, the cytoprotective effects of OLE against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in HaCaT cells were evaluated. In the model group, cells exposed to H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#x3bc;M) had reduced cell viability by 76.9%. OLE (at concentrations of 12.5, 25, 50, and 100&#xa0;&#x3bc;M) was non-toxic to HaCaT cells (with &#x3e;100% cell viability; <xref ref-type="fig" rid="F2">Figure 2B</xref>) and it reduced H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity by increasing the cell viability to 81.3%, 80.5%, 81.8%, and 84.0% at the concentrations of 12.5, 25, 50, and 100&#xa0;&#x3bc;M, respectively (<xref ref-type="fig" rid="F2">Figure 2C</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Protective effects of OLE on LPS and nigericin-THP-1 conditioned media induced cytotoxicity of HaCaT cells <bold>(A)</bold>. Effects of OLE on the viability of HaCaT cells without <bold>(B)</bold> or with <bold>(C)</bold> H<sub>2</sub>O<sub>2</sub>. <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.0001 compared with the control group; &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 as compared with the H<sub>2</sub>O<sub>2</sub>-treated or LPS &#x2b; Nig group.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g002.tif"/>
</fig>
<p>This cytoprotective effect was further investigated by assessing the effects of OLE on the cyclic progression of HaCaT cells exposed to H<sub>2</sub>O<sub>2</sub>. The flow cytometric analysis revealed that stimulation with H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#x3bc;M) altered cell cycle distribution including phases of G2-M, S, and G0-G1, compared to the control group. Treatment with OLE (100&#xa0;&#x3bc;M) attenuated H<sub>2</sub>O<sub>2</sub>-induced cell cycle transition as it reduced the S phase by 7.5% (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Effect of OLE on the cell-cycle progression in HaCaT cells analyzed by flow cytometry <bold>(A)</bold>, and quantification of the mean fluorescence intensity <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g003.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 OLE attenuates H<sub>2</sub>O<sub>2</sub>-induced reactive oxygen species (ROS) in HaCaT cells</title>
<p>To further evaluate the cytoprotective effect of OLE on HaCaT cells, we studied if OLE could attenuate H<sub>2</sub>O<sub>2</sub>-induced ROS in HaCaT cells. A fluorescent probe 2&#x2032;,7&#x2032;-dichlorodihydrofluorescein diacetate (DCF-DA) was used to measure the total ROS level in HaCaT. In HaCaT cells, H<sub>2</sub>O<sub>2</sub>-induced oxidative stress increased the production of cellular ROS production by 7.9-fold compared to the control group, while OLE (at concentrations of 12.5, 25, 50, and 100&#xa0;&#x3bc;M) decreased the formation of the oxidized fluorescent product 2&#x2032;,7&#x2032;-dichlorofluorescein to 2.6-, 3.9-, 5.2-, and 6.0-fold, respectively (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Given that mitochondria are responsible for major cellular ROS (<xref ref-type="bibr" rid="B30">Tirichen et al., 2021</xref>), we used CellROX, a cell-permeant fluorogenic agent that specifically stains mitochondrial ROS, to assess OLE&#x2019;s antioxidant effects. As shown in <xref ref-type="fig" rid="F4">Figure 4B</xref>, H<sub>2</sub>O<sub>2</sub>-induced mitochondrial ROS was increased by 135.6% compared to the control group and OLE decreased the mitochondrial ROS by 22.6% compared to the H<sub>2</sub>O<sub>2</sub> group.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effects of OLE on the total production of ROS <bold>(A)</bold> and cellular mitochondrial ROS <bold>(B)</bold> in H<sub>2</sub>O<sub>2</sub>-exposed HaCaT cells. <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.0001 as compared with control group, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 as compared with H<sub>2</sub>O<sub>2</sub> group.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g004.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 OLE modulates the gene expression of IL-1&#x3b2; and TXNIP</title>
<p>Given that excessive cellular ROS may trigger the activation of NLRP3 and lead to the formation of inflammasome complex (<xref ref-type="bibr" rid="B5">Choi and Park, 2023</xref>), OLE&#x2019;s effect on the expression of inflammasome-related genes in HaCaT cells was explored with a multiplexed gene expression assay (see the list of full genes in this panel in the <xref ref-type="sec" rid="s11">Supplementary Materials</xref>). The results revealed that stimulation with H<sub>2</sub>O<sub>2</sub> increased the mRNA expression levels of genes including IL-1&#x3b2; and TXNIP (thioredoxin-interacting protein) by 19.9% and 25.6%, respectively, compared to the control group (<xref ref-type="fig" rid="F5">Figure 5</xref>). Treatment with OLE downregulated the mRNA expression levels of genes IL1&#x3b2; and TXNIP by 21.6% and 22.8%, respectively, compared to the H<sub>2</sub>O<sub>2</sub>-stimulated cells.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Effects of OLE on the mRNA expression levels of inflammasome-related genes measured by the multiplexed gene expression assay. Statistical analysis used a two-way analysis of variance with multiple comparisons. <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01, <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.0001 as compared with the control group; &#x2a;<italic>p</italic> &#x3c; 0.05 as compared with the H<sub>2</sub>O<sub>2</sub> group.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g005.tif"/>
</fig>
<p>IL-1&#x3b2; is a well-studied pro-inflammatory cytokine that plays a critical role in mediating and amplifying inflammation. It is part of the body&#x2019;s innate immune response and is produced by a variety of cells, primarily macrophages and monocytes, in response to infections, tissue damage, or other stressors (<xref ref-type="bibr" rid="B20">Lopez-Castejon and Brough, 2011</xref>). On the other hand, TXNIP is a key regulator of oxidative stress and cellular redox balance. It can dictate the response to oxidative by several mechanisms including the inhibition of thioredoxin (TRX), activation of NLRP3 inflammasome, and regulation of metabolic pathways (<xref ref-type="bibr" rid="B9">Lane et al., 2013</xref>). OLE has been reported to reduce inflammation by modulating NLRP3 inflammasome. For instance, OLE was reported to inhibit murine lupus nephritis NLRP3 inflammasome-related signaling pathways (<xref ref-type="bibr" rid="B4">Castejon et al., 2019</xref>). Thus, it is not surprising that OLE treatment significantly reduced the expression of IL-1&#x3b2; in and TXNIP the multiplexed gene assay. However, further functional studies were warranted to confirm OLE&#x2019;s effects on caspase-1.</p>
</sec>
<sec id="s3-5">
<title>3.5 OLE decreases cellular IL-1&#x3b2; and caspase-1 level in H<sub>2</sub>O<sub>2</sub>-stimulated HaCaT cells</title>
<p>Based on the multiplexed gene assay, IL-1&#x3b2; could be a critical gene that regulates OLE&#x2019;s antioxidant and anti-inflammatory effects in HaCaT cells. Thus, we evaluated OLE&#x2019;s effects on the cellular IL-1&#x3b2; level in H<sub>2</sub>O<sub>2</sub>-stimulated HaCaT cells. Stimulation with H<sub>2</sub>O<sub>2</sub> (200&#xa0;&#x3bc;M) elevated the level of cellular IL-1&#x3b2; in HaCaT cells by 111.3%, which was counteracted by the treatment with OLE (50 and 100&#xa0;&#x3bc;M) by 11.5%, 12.2%, 16.3%, and 43.8%, respectively (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Additionally, the production of IL-1&#x3b2; is regulated by caspase-1 and it is unknown whether OLE can decrease IL-1&#x3b2; by inhibiting the activity of caspase-1 (a precursor of IL-1&#x3b2;). Therefore, we also evaluated OLE&#x2019;s inhibitory effect on the activity of caspase-1 enzyme and revealed that OLE inhibited caspase-1 activity by 13.4% (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Next, we evaluated whether OLE alleviated pyroptosis, a form of inflammation-mediated programmed cell death activated by caspase 1 (<xref ref-type="bibr" rid="B22">Man et al., 2017</xref>). Several key events including the rapid formation of membrane pores, significant cell swelling, and subsequent membrane rupture, releasing intracellular contents, such as cytosolic proteins (e.g., lactate dehydrogenase; LDH), are associated with pyroptosis (<xref ref-type="bibr" rid="B28">Rayamajhi et al., 2013</xref>). Thus, OLE&#x2019;s effect on H<sub>2</sub>O<sub>2</sub> (100&#xa0;&#x3bc;M) elevated LDH production (by 59.8%) in HaCaT cells was assessed. Treatment with OLE (25, 50, and 100&#xa0;&#x3bc;M) decreased the LDH production by 17.2%, 28.6%, and 38.1%, respectively, compared to the model group (<xref ref-type="fig" rid="F6">Figure 6C</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Effects of OLE on the release of cellular IL-1&#x3b2; <bold>(A)</bold>, caspase-1 enzyme activity <bold>(B, C)</bold> LDH release in HaCaT cells. <sup>&#x23;&#x23;&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.0001 as compared with the control group. &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001 as compared with the H<sub>2</sub>O<sub>2</sub>-treated group.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g006.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 OLE induces proteome changes in H<sub>2</sub>O<sub>2</sub>-stimulated HaCaT cells</title>
<p>We conducted a bottom-up proteomics analysis using SWATH-MS to investigate the impact of OLE on proteome changes in H&#x2082;O&#x2082;-stimulated HaCaT cells. A DirectDIA analysis initially identified 3,288 proteins. After reprocessing the data with msDiaLogue and applying a stringent filtering step to exclude 777 proteins identified by fewer than two unique peptides, 2,511 reliable proteins were retained. As shown in <xref ref-type="fig" rid="F7">Figure 7</xref>, compared to the control group, there were 77 upregulated and 5 downregulated proteins in H<sub>2</sub>O<sub>2</sub>-stimulated HaCaT cells (Model group). Comparing the OLE treatment group to the Model group, 7 proteins were upregulated and 1 was downregulated. However, when applying a more stringent threshold of a 1.5-fold change (Log2FC &#x3e; 0.58 and Log2FC &#x3c;&#x2212;0.58) and a <italic>p</italic>-value of less than 0.05, no proteins from the OLE treatment group counter-regulated the proteome changes induced by oxidative stress. Overall, we identified fourteen proteins, of which thirteen were upregulated in the Model group and downregulated by OLE, while one was downregulated in the Model group and upregulated by OLE (<xref ref-type="fig" rid="F8">Figure 8</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Volcano plot of downregulated and upregulated proteins after H<sub>2</sub>O<sub>2</sub> stimulation compared to the control group(A), and OLE group compared to the H<sub>2</sub>O<sub>2</sub> group. The volcano plots were generated using a cut-off value of 0.58 (1.5-fold change) and a <italic>p</italic>-value &#x3c;0.05. The x-axis represents the log2 fold change, and the y-axis represents the negative log10 <italic>p</italic>-value.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g007.tif"/>
</fig>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Effects of OLE on protein expression levels of oxidative press-related proteins measured by the proteomics assay. Statistical analysis used a one-way ANOVA analysis of variance with multiple comparisons. <sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 as compared with the control group; &#x2a;<italic>p</italic> &#x3c; 0.05, <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c; 0.01 as compared with the H<sub>2</sub>O<sub>2</sub> group.</p>
</caption>
<graphic xlink:href="fphar-15-1496078-g008.tif"/>
</fig>
<p>Expressions of several proteins including HO2, DDX51, NOL11, SAR1&#x3b1;, and TMED5 were significantly elevated by oxidative stress in the model group (<xref ref-type="fig" rid="F8">Figure 8</xref>). Of these proteins, treatment with OLE counteracted the protein expressions of HO2, DDX51, and TMED5. Several proteins modulated by OLE treatment in response to oxidative stress are potential targets contributed to OLE&#x2019;s antioxidant effects. The HO2 protein, also known as heme oxygenase-2, plays a significant role in the cellular antioxidant defense system. HO2 can degrade heme, which is a component of hemoglobin, into biliverdin, carbon monoxide, and free iron. The breakdown products, such as biliverdin and its reduced form bilirubin, have potent antioxidant properties (<xref ref-type="bibr" rid="B7">Intagliata et al., 2019</xref>). In the model group, cells exposed to H<sub>2</sub>O<sub>2</sub> had higher expression of HO2 protein, suggesting that this protein could play a critical role in mediating oxidative stress in HaCaT cells. This is in agreement with previously reported studies showing that HO-1 exerts antioxidant effects in human keratinocytes, which is associated with the production of inflammatory cytokines (<xref ref-type="bibr" rid="B23">Numata et al., 2009</xref>). Moreover, oleuropein is reported to modulate HO1 protein, an isoenzyme form of HO2, to alleviate oxidative stress in liver tissue (<xref ref-type="bibr" rid="B6">Domitrovi&#x107; et al., 2012</xref>).</p>
<p>An ingenuity pathway analysis (IPA) was performed to elucidate the signaling pathways affected by H<sub>2</sub>O<sub>2</sub> stimulation. Compared to the control group, several top canonical pathways including mitotic metaphase and anaphase (<italic>p</italic> &#x3d; 2.47 &#xd7; 10&#x207b;<sup>10</sup>), RHO GTPases activate formins (<italic>p</italic> &#x3d; 7.34 &#xd7; 10&#x207b;<sup>10</sup>), and mitotic prometaphase (<italic>p</italic> &#x3d; 1.67 &#xd7; 10&#x207b;<sup>9</sup>) in the oxidative stress model were involved (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Predicted top canonical pathways were derived from IPA analysis for the control and the oxidative stress model groups.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Top canonical pathways</th>
<th align="center">
<italic>p</italic>-value</th>
<th align="center">Overlap</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Sirtuin Signaling Pathway</td>
<td align="center">1.65E-11</td>
<td align="center">7.3% (21/286)</td>
</tr>
<tr>
<td align="center">Mitotic G2-G2/M</td>
<td align="center">1.45E-10</td>
<td align="center">8.5% (17/199)</td>
</tr>
<tr>
<td align="center">Mitotic Metaphase and Anaphase</td>
<td align="center">2.47E-10</td>
<td align="center">7.7% (18/235)</td>
</tr>
<tr>
<td align="center">RHO GTPases Activate Formins</td>
<td align="center">7.34E-10</td>
<td align="center">10.1% (14/139)</td>
</tr>
<tr>
<td align="center">Mitotic Promephase</td>
<td align="center">1.67E-09</td>
<td align="center">7.9% (16/203)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The IPA results predicted the activation of key upstream regulators such as APP (amyloid-beta precursor protein; <italic>p</italic> &#x3d; 5.46 &#xd7; 10&#x207b;<sup>9</sup>), MYC (MYC proto-oncogene; <italic>p</italic> &#x3d; 1.78 &#xd7; 10&#x207b;<sup>8</sup>), TGFB1 (transforming growth factor beta 1; <italic>p</italic> &#x3d; 1.12 &#xd7; 10&#x207b;<sup>13</sup>), FCER1G (Fc fragment of IgE; <italic>p</italic> &#x3d; 3.97 &#xd7; 10&#x207b;<sup>12</sup>), ABL1 (tyrosine-protein kinase ABL1; <italic>p</italic> &#x3d; 6.17 &#xd7; 10&#x207b;<sup>12</sup>), and PML (promyelocytic leukemia protein; <italic>p</italic> &#x3d; 1.47 &#xd7; 10&#x207b;<sup>11</sup>), while CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1; <italic>p</italic> &#x3d; 8.52 &#xd7; 10&#x207b;<sup>12</sup>) was predicted to be inhibited by H<sub>2</sub>O<sub>2</sub> stimulation (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Predicted top upstream regulators from IPA analysis for the control and the oxidative stress model groups.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Top upstream regulators or causal network</th>
<th align="center">
<italic>p</italic>-value</th>
<th align="center">Predicted activation</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">APP</td>
<td align="center">5.46E-09</td>
<td align="center">Activated</td>
</tr>
<tr>
<td align="center">MYC</td>
<td align="center">1.78E-08</td>
<td align="center">Activated</td>
</tr>
<tr>
<td align="center">TGFB1</td>
<td align="center">1.12E-13</td>
<td align="center">Activated</td>
</tr>
<tr>
<td align="center">FCER1G</td>
<td align="center">3.97E-12</td>
<td align="center">Activated</td>
</tr>
<tr>
<td align="center">ABL1</td>
<td align="center">6.17E-12</td>
<td align="center">Activated</td>
</tr>
<tr>
<td align="center">CEACAM1</td>
<td align="center">8.52E-12</td>
<td align="center">Activated</td>
</tr>
<tr>
<td align="center">PML</td>
<td align="center">1.47E-11</td>
<td align="center">Activated</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Our group has used the proteomics approach to study the molecule pathways in human keratinocytes in the condition of oxidative stress (<xref ref-type="bibr" rid="B11">Li et al., 2023</xref>). We optimized this method to study OLE&#x2019;s mechanisms of action. Among these canonical pathways identified by proteomics, the sirtuin pathway consisting of a family of NAD &#x2b; -dependent deacetylases is a classic master regulator involved in mediating cellular oxidative stress response. This pathway plays a crucial role in cellular homeostasis by influencing DNA repair, mitochondrial function, and apoptosis (<xref ref-type="bibr" rid="B29">Salminen et al., 2013</xref>). Under oxidative stress, sirtuins (particularly SIRT1) modulate the activity of key transcription factors like FOXO and PGC-1&#x3b1;, which control antioxidant defenses. Activation of sirtuins promotes cellular survival by reducing ROS production and enhancing mitochondrial biogenesis. This was in agreement with data from our cellular assays and numerous studies showing that H<sub>2</sub>O<sub>2</sub> can induce oxidative stress in HaCaT cells by modulating the SIRT pathways (<xref ref-type="bibr" rid="B2">Cao et al., 2009</xref>; <xref ref-type="bibr" rid="B10">Lee et al., 2016</xref>). Additionally, proteomics analysis identified the mitotic G2-G2/M pathway as an important biomarker for H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in HaCaT cells. This is not surprising given that the mitotic G2-G2/M pathway is a checkpoint that ensures cells with DNA damage do not enter mitosis, allowing time for repair (<xref ref-type="bibr" rid="B31">Wang et al., 2017</xref>). Moreover, the role of the mitotic G2-G2/M pathway in response to oxidative stress is supported by data from our flow cytometric assays showing that the G2/M phase of HaCaT cells was affected by exposure to H<sub>2</sub>O<sub>2</sub>. To date, this is the first study showing that the mitotic G2-G2/M pathway is a biomarker for oxidative stress in HaCaT cells. This demonstrates that our proteomics study identified new molecular targets involved in OLE&#x2019;s response to oxidative stress in human keratinocytes.</p>
<p>Next, our proteomics analysis revealed that OLE treatment regulated several top canonical pathways including the processing of capped intron-containing pre-mRNA (<italic>p</italic> &#x3d; 1.84 &#xd7; 10&#x207b;<sup>34</sup>), FAT10 signaling pathway (<italic>p</italic> &#x3d; 2.67 &#xd7; 10&#x207b;<sup>31</sup>), regulation of apoptosis (<italic>p</italic> &#x3d; 6.84 &#xd7; 10&#x207b;<sup>30</sup>), metabolism of polyamines (<italic>p</italic> &#x3d; 1.25 &#xd7; 10&#x207b;<sup>28</sup>), and noncanonical NF-&#x3ba;B signaling (<italic>p</italic> &#x3d; 1.96 &#xd7; 10&#x207b;<sup>28</sup>) (<xref ref-type="table" rid="T3">Table 3</xref>). Additionally, several key upstream regulators such as 5-methyltetrahydrofolic acid (<italic>p</italic> &#x3d; 1.01 &#xd7; 10&#x207b;<sup>29</sup>), folic acid (<italic>p</italic> &#x3d; 1.12 &#xd7; 10&#x207b;<sup>27</sup>), WTAP (WT1 associated protein; <italic>p</italic> &#x3d; 4.44 &#xd7; 10&#x207b;<sup>21</sup>), and NFE2L1 (nuclear factor erythroid 2 like 1; <italic>p</italic> &#x3d; 7.95 &#xd7; 10&#x207b;<sup>15</sup>) were predicted to be activated by OLE treatment (<xref ref-type="table" rid="T4">Table 4</xref>).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Predicted top canonical pathways were derived from IPA analysis for the OLE treatment and the model groups.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Top canonical pathways</th>
<th align="center">
<italic>p</italic>-value</th>
<th align="center">Overlap</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Processing of capped intro-containing Pre-mRNA</td>
<td align="center">1.65E-11</td>
<td align="center">7.3% (21/286)</td>
</tr>
<tr>
<td align="center">FAT10 Signaling Pathway</td>
<td align="center">1.45E-10</td>
<td align="center">8.5% (17/199)</td>
</tr>
<tr>
<td align="center">Regulation of Apoptosis</td>
<td align="center">2.47E-10</td>
<td align="center">7.7% (18/235)</td>
</tr>
<tr>
<td align="center">Metabolism of polyamines</td>
<td align="center">7.34E-10</td>
<td align="center">10.1% (14/139)</td>
</tr>
<tr>
<td align="center">Noncanonical NF-KB signaling</td>
<td align="center">1.67E-09</td>
<td align="center">7.9% (16/203)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Predicted top upstream regulators from IPA analysis for OLE treatment and the model groups.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Upstream regulators or causal network</th>
<th align="center">
<italic>p</italic>-value</th>
<th align="center">Overlap</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">5-methyletrahydrofolic acid</td>
<td align="center">1.65E-11</td>
<td align="center">7.3% (21/286)</td>
</tr>
<tr>
<td align="center">Folic acid</td>
<td align="center">1.45E-10</td>
<td align="center">8.5% (17/199)</td>
</tr>
<tr>
<td align="center">WTAP</td>
<td align="center">2.47E-10</td>
<td align="center">7.7% (18/235)</td>
</tr>
<tr>
<td align="center">NFE2L1</td>
<td align="center">7.34E-10</td>
<td align="center">10.1% (14/139)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Among the identified canonical pathways, the processing of capped intron-containing pre-mRNA pathway involves the processing and splicing of pre-mRNA, which includes adding a 5&#x2032;cap to protect the RNA from degradation and facilitating splicing by removing introns. Under oxidative stress, splicing can be disrupted due to ROS affecting the spliceosome machinery and RNA-binding proteins. This leads to errors in mRNA processing and potentially abnormal protein synthesis. Oxidative stress-induced damage to RNA itself can also impact this pathway, contributing to cellular dysfunction (<xref ref-type="bibr" rid="B13">Ling et al., 2017</xref>). Although this is the first study suggesting that the processing of capped intron-containing pre-mRNA pathway is a potential biomarker for OLE&#x2019;s antioxidant effects in HaCaT cells, further studies of functional assays are warranted to confirm it. Nevertheless, the proteomics study also identified pathways that have been reported for OLE&#x2019;s antioxidant activities. For instance, proteomics identified the noncanonical NF-&#x3ba;B signaling involved in OLE&#x2019;s antioxidant effects in HaCaT cells. Unlike the classical NF-&#x3ba;B pathway, which is rapidly activated by pro-inflammatory signals, the noncanonical NF-&#x3ba;B pathway is activated by specific signals like lymphotoxin, playing a slower role in immune regulation. In oxidative stress, this pathway contributes to cellular survival by regulating genes involved in antioxidant responses, immune function, and inflammation. It can be activated by ROS through kinase signaling cascades, enabling cells to adapt and survive oxidative conditions&#x200b; (<xref ref-type="bibr" rid="B14">Lingappan, 2018</xref>). Oleuropein has been reported to interfere with NF-&#x3ba;B signaling pathways, reducing inflammation and oxidative stress in peritoneal macrophages (<xref ref-type="bibr" rid="B3">Castej&#xf3;n et al., 2020</xref>). This is supported by our experiments showing that OLE downregulated pro-inflammatory cytokines and upregulated antioxidant defenses, which protects HaCaT cells from oxidative damage and chronic inflammation. Furthermore, it was noted that NFE2L1, nuclear factor erythroid 2 like 1 (also known as Nrf1), was identified as a molecular target for OLE&#x2019;s antioxidative effects. NFE2L1 has been studied as a transcription factor that plays a critical role in cellular responses to oxidative stress. It mediates oxidative stress through several mechanisms including regulation of antioxidant gene expression (e.g., superoxide dismutase and glutathione peroxidase), proteasomal homeostasis, and as a complementary role to NFE2L2 (Nrf2) to compensate for loss of Nrf2 function (<xref ref-type="bibr" rid="B18">Liu et al., 2023</xref>). Studies have shown that OLE can induce mitochondrial biogenesis and decrease reactive oxygen species generation in cultured avian muscle cells via the modulation of SIRT1 and Nrf1 gene expression (<xref ref-type="bibr" rid="B8">Kikusato et al., 2016</xref>). The current study demonstrates that OLE may modulate NFE2L1 to alleviate oxidative stress in HaCaT cells. Our findings provide evidence for OLE&#x2019;s skin-protective effects using proteomic analysis, identifying key proteins and pathways involved in its antioxidant and anti-inflammatory actions. However, to confirm these findings, functional assays like Western blotting, immunohistochemistry, and qRT-PCR are needed to validate the proteomic results at the protein and gene expression levels. These assays would strengthen the understanding of OLE&#x2019;s mechanisms of action, which are critical for its potential development as an active ingredient for skin health.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>In summary, we evaluated the anti-inflammatory and antioxidant activities of OLE in human monocytes and keratinocytes with a panel of biochemical assays. OLE exerts anti-inflammatory effects by reducing the level of pro-inflammatory cytokine in human THP-1 cells. Additionally, in a non-contact co-culture model (with condition cell culture medium from THP-1 cells), OLE protects HaCaT cells by ameliorating inflammatory stress-induced cytotoxicity. Moreover, OLE protects HaCaT cells by reducing ROS production and mediating cell cycles. The plausible mechanism(s) for OLE&#x2019;s anti-inflammatory and antioxidant activities were explored by a multiplexed gene expression assay, which identified enzymes including caspase-1 as the potential targets. Furthermore, a bottom-up proteomics study characterized a series of canonical pathways and upstream regulators that may contribute to OLE&#x2019;s overall biological effects. Data from the current study provide useful information to support OLE&#x2019;s skin protective effects, which expands our understanding of OLE&#x2019;s effects as a promising cosmeceutical.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The data generated and analyzed in this study have been deposited in the MassIVE repository (<ext-link ext-link-type="uri" xlink:href="https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp">https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp</ext-link>) under the project identifier &#x201c;MassIVE MSV000096730.&#x201d; The dataset is accessible via the FTP link: <ext-link ext-link-type="uri" xlink:href="ftp://massive.ucsd.edu/v07/MSV000096730/">ftp://massive.ucsd.edu/v07/MSV000096730/</ext-link>. For further details or inquiries, please contact CL at <email>hichang813@uri.edu</email>.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>HL: Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing&#x2013;original draft. ND: Data curation, Formal analysis, Methodology, Visualization, Writing&#x2013;original draft. JY: Investigation, Writing&#x2013;original draft. YZ: Investigation, Writing&#x2013;original draft. XJ: Investigation, Writing&#x2013;original draft. AC: Investigation, Writing&#x2013;original draft, Writing&#x2013;review and editing. NS: Project administration, Resources, Supervision, Writing&#x2013;review and editing. HM: Project administration, Supervision, Writing&#x2013;review and editing. DL: Project administration, Supervision, Writing&#x2013;review and editing. HY: Project administration, Supervision, Writing&#x2013;review and editing. CL: Conceptualization, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This project was partially supported by a research contract between URI (to CL) and Y&#x26;G Medical Inc. (Boxborough, MA, United States). Y&#x26;G was not involved in the design, investigation, and presentation of this study. Several instruments used for the completion of this study were located in the RI-INBRE core facility supported by Grant &#x23;P20GM103430 from the National Institute of General Medical Sciences of the National Institutes of Health. Additionally, CL received support through a Pilot Grant Award from the College of Pharmacy, University of Rhode Island, and a Pilot Project under the CardioPulmonary Vascular Biology (CPVB) COBRE (P20GM103652).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2024.1496078/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2024.1496078/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allaw</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Manca</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>G&#xf3;mez-Fern&#xe1;ndez</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Pedraz</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Terencio</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Sales</surname>
<given-names>O. D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Oleuropein multicompartment nanovesicles enriched with collagen as A natural strategy for the treatment of skin wounds connected with oxidative stress</article-title>. <source>Nanomedicine</source> <volume>16</volume>, <fpage>2363</fpage>&#x2013;<lpage>2376</lpage>. <pub-id pub-id-type="doi">10.2217/nnm-2021-0197</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kivlin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wallin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Card</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bagdasarian</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes</article-title>. <source>J. Cell. Mol. Med.</source> <volume>13</volume>, <fpage>3632</fpage>&#x2013;<lpage>3643</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00453.x</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castej&#xf3;n</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Montoya</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Alarc&#xf3;n-de-la-Lastra</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez-Benjumea</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>V&#xe1;zquez-Rom&#xe1;n</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Hidalgo</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Dietary oleuropein and its acyl derivative ameliorate inflammatory response in peritoneal macrophages from pristane-induced SLE mice via canonical and noncanonical NLRP3 inflammasomes pathway</article-title>. <source>Food Funct.</source> <volume>11</volume>, <fpage>6622</fpage>&#x2013;<lpage>6631</lpage>. <pub-id pub-id-type="doi">10.1039/D0FO00235F</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castejon</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Hidalgo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aparicio-Soto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Montoya</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mart&#xed;n-LaCave</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Bola&#xf1;os</surname>
<given-names>J. G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Dietary oleuropein and its new acyl-derivate attenuate murine lupus nephritis through HO-1/Nrf2 activation and suppressing JAK/STAT, NF-&#x3ba;B, MAPK and NLRP3 inflammasome signaling pathways</article-title>. <source>J. Nutr. Biochem.</source> <volume>74</volume>, <fpage>108229</fpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2019.108229</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>E.-H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S.-J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>TXNIP: a key protein in the cellular stress response pathway and a potential therapeutic target</article-title>. <source>Exp. Mol. Med.</source> <volume>55</volume>, <fpage>1348</fpage>&#x2013;<lpage>1356</lpage>. <pub-id pub-id-type="doi">10.1038/s12276-023-01019-8</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domitrovi&#x107;</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jakovac</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Marchesi</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>&#x160;ain</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Romi&#x107;</surname>
<given-names>&#x17d;.</given-names>
</name>
<name>
<surname>Raheli&#x107;</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Preventive and therapeutic effects of oleuropein against carbon tetrachloride-induced liver damage in mice</article-title>. <source>Pharmacol. Res.</source> <volume>65</volume>, <fpage>451</fpage>&#x2013;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2011.12.005</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Intagliata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Salerno</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ciaffaglione</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Leonardi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fallica</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Carota</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Heme Oxygenase-2 (HO-2) as a therapeutic target: activators and inhibitors</article-title>. <source>Eur. J. Med. Chem.</source> <volume>183</volume>, <fpage>111703</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111703</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kikusato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Muroi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Uwabe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Furukawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Toyomizu</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Oleuropein induces mitochondrial biogenesis and decreases reactive oxygen species generation in cultured avian muscle cells, possibly via an up-regulation of peroxisome proliferator-activated receptor &#x3b3; coactivator-1&#x3b1;</article-title>. <source>Animal Sci. J.</source> <volume>87</volume>, <fpage>1371</fpage>&#x2013;<lpage>1378</lpage>. <pub-id pub-id-type="doi">10.1111/asj.12559</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lane</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Flam</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lockey</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kolliputi</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>TXNIP shuttling: missing link between oxidative stress and inflammasome activation</article-title>. <source>Front. Physiol.</source> <volume>4</volume>, <fpage>50</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2013.00050</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Nazim</surname>
<given-names>U. M. D.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Seol</surname>
<given-names>J.-W.</given-names>
</name>
<name>
<surname>Eo</surname>
<given-names>S.-K.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Melatonin protects skin keratinocyte from hydrogen peroxide-mediated cell death via the SIRT1 pathway</article-title>. <source>Oncotarget</source> <volume>7</volume>, <fpage>12075</fpage>&#x2013;<lpage>12088</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.7679</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Puopolo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Seeram</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Cannflavins A and B with anti-ferroptosis, anti-glycation, and antioxidant activities protect human keratinocytes in a cell death model with erastin and reactive carbonyl species</article-title>. <source>Nutrients</source> <volume>15</volume>, <fpage>4565</fpage>. <pub-id pub-id-type="doi">10.3390/nu15214565</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Akanji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gutkowski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Dietary polyphenol oleuropein and its metabolite hydroxytyrosol are moderate skin permeable elastase and collagenase inhibitors with synergistic cellular antioxidant effects in human skin fibroblasts</article-title>. <source>Int. J. Food Sci. Nutr.</source> <volume>73</volume>, <fpage>460</fpage>&#x2013;<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1080/09637486.2021.1996542</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ling</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Alshareef</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Butt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lozano-Juste</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Galal</surname>
<given-names>A. A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Pre-mRNA splicing repression triggers abiotic stress signaling in plants</article-title>. <source>Plant J.</source> <volume>89</volume>, <fpage>291</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1111/tpj.13383</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lingappan</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>NF-&#x3ba;B in oxidative stress</article-title>. <source>Curr. Opin. Toxicol.</source> <volume>7</volume>, <fpage>81</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.cotox.2017.11.002</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>DaSilva</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Pomegranate (<italic>Punica granatum</italic>) phenolics ameliorate hydrogen peroxide-induced oxidative stress and cytotoxicity in human keratinocytes</article-title>. <source>J. Funct. Foods</source> <volume>54</volume>, <fpage>559</fpage>&#x2013;<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2019.02.015</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Seeram</surname>
<given-names>N. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cannabidiol protects human skin keratinocytes from hydrogen-peroxide-induced oxidative stress via modulation of the caspase-1-IL-1&#x3b2; Axis</article-title>. <source>J. Nat. Prod.</source> <volume>84</volume>, <fpage>1563</fpage>&#x2013;<lpage>1572</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.1c00083</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Slitt</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Seeram</surname>
<given-names>N. P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Inhibitory effect of cannabidiol on the activation of NLRP3 inflammasome is associated with its modulation of the P2X7 receptor in human monocytes</article-title>. <source>J. Nat. Prod.</source> <volume>83</volume>, <fpage>2025</fpage>&#x2013;<lpage>2029</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.0c00138</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Unravelling the role of NFE2L1 in stress responses and related diseases</article-title>. <source>Redox Biol.</source> <volume>65</volume>, <fpage>102819</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2023.102819</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The olive constituent oleuropein exerts nephritic protective effects on diabetic nephropathy in db/db mice</article-title>. <source>Archives Physiology Biochem.</source> <volume>128</volume>, <fpage>455</fpage>&#x2013;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1080/13813455.2019.1691603</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Castejon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brough</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Understanding the mechanism of IL-1&#x3b2; secretion</article-title>. <source>Cytokine and Growth Factor Rev.</source> <volume>22</volume>, <fpage>189</fpage>&#x2013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2011.10.001</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>DaSilva</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nahar</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Effects of a standardized phenolic-enriched maple syrup extract on &#x3b2;-amyloid aggregation, neuroinflammation in microglial and neuronal cells, and &#x3b2;-amyloid induced neurotoxicity in Caenorhabditis elegans</article-title>. <source>Neurochem. Res.</source> <volume>41</volume>, <fpage>2836</fpage>&#x2013;<lpage>2847</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-016-1998-6</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Man</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Karki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kanneganti</surname>
<given-names>T.-D.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases</article-title>. <source>Immunol. Rev.</source> <volume>277</volume>, <fpage>61</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12534</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Numata</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Okuyama</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Memezawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Furuyama</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Functional expression of heme oxygenase-1 in human differentiated epidermis and its regulation by cytokines</article-title>. <source>J. Investigative Dermatology</source> <volume>129</volume>, <fpage>2594</fpage>&#x2013;<lpage>2603</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2009.119</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Omar</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Oleuropein in olive and its pharmacological effects</article-title>. <source>Sci. Pharm.</source> <volume>78</volume>, <fpage>133</fpage>&#x2013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.3797/scipharm.0912-18</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piipponen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Land&#xe9;n</surname>
<given-names>N. X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The immune functions of keratinocytes in skin wound healing</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>, <fpage>8790</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21228790</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puopolo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schrader</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Seeram</surname>
<given-names>N. P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Uncovering the anti-inflammatory mechanisms of phenolic-enriched maple syrup extract in lipopolysaccharide-induced peritonitis in mice: insights from data-independent acquisition proteomics analysis</article-title>. <source>Food Funct.</source> <volume>14</volume>, <fpage>6690</fpage>&#x2013;<lpage>6706</lpage>. <pub-id pub-id-type="doi">10.1039/D3FO01386C</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puopolo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Seeram</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Chloroform/methanol protein extraction and in-solution trypsin digestion protocol for bottom-up proteomics analysis</article-title>. <source>Bio Protoc.</source> <volume>14</volume>, <fpage>e5055</fpage>. <pub-id pub-id-type="doi">10.21769/BioProtoc.5055</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rayamajhi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Detection of pyroptosis by measuring released lactate dehydrogenase activity</article-title>. <source>Methods Mol. Biol.</source> <volume>1040</volume>, <fpage>85</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-62703-523-1_7</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salminen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaarniranta</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kauppinen</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Crosstalk between oxidative stress and SIRT1: impact on the aging process</article-title>. <source>Int. J. Mol. Sci.</source> <volume>14</volume>, <fpage>3834</fpage>&#x2013;<lpage>3859</lpage>. <pub-id pub-id-type="doi">10.3390/ijms14023834</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tirichen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yaigoub</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress</article-title>. <source>Front. Physiol.</source> <volume>12</volume>, <fpage>627837</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2021.627837</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.-F.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Oxidative stress induces mitotic arrest by inhibiting Aurora A-involved mitotic spindle formation</article-title>. <source>Free Radic. Biol. Med.</source> <volume>103</volume>, <fpage>177</fpage>&#x2013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2016.12.031</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>